Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
18.50    0.00 (0.00%)
Bid:
18.00
Ask:
19.00
Spread: 1.00 (5.556%)
Market Cap: £16.76m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

ACQUISITION OF INNOVATIONBUBBLE

27 Jul 2020 07:00

RNS Number : 0797U
Mission Group PLC (The)
27 July 2020
 

27 July 2020

 

THE MISSION GROUP plc

("MISSION", "THE GROUP")

 

ACQUISITION OF INNOVATIONBUBBLE

 

MISSION (AIM: TMG), the alternative group for ambitious brands, is pleased to announce the acquisition of Innovationbubble, the international psychological insights and behavioural solutions consultancy.

 

Innovationbubble will sit at the heart of the Group's business model, extending the expertise and capabilities that it provides to its global network of Agencies through the 'MISSION Advantage.' The consultancy provides research and advice to a growing portfolio of clients from blue-chips including Asda, Aviva, HSBC and a number of leading pharmaceutical businesses, to high profile brands such as Diesel and SpaceNK, helping them better understand what drives the behaviour of their customers and ultimately how to improve marketing activity. 

 

James Clifton, Chief Executive of The MISSION Group plc, commented: 

 

"MISSION has a strong track record of integrating earning accretive acquisitions, broadening the Group's range of services, geographic reach and sector expertise. I believe the Covid-19 pandemic will present new opportunities for our business and this acquisition is early testament to our ambitions. 

 

"We are delighted to welcome the Innovationbubble team into MISSION. In the current environment, their unique insight into customer psychology and behaviour is hugely valuable as businesses look to capitalise on the shifting trends we have seen during these unprecedented times. I am confident their expertise will be an important addition to the suite of services we offer our clients through MISSION Advantage and look forward to working with Dr Simon and the team."

 

Dr Simon Moore, CEO of Innovationbubble, said:

 

"MISSION is a fantastic business and the collaborative culture and entrepreneurial spirit which the Group has fostered made them the natural partner for us. 

 

"We are looking forward to becoming part of MISSION and excited to be working with James and the team as the Group continues to build on its impressive growth to date."

 

David Morgan, Chairman of MISSION, added:

 

"In an enormously challenging environment, MISSION has thus far performed remarkably well as a business and the complementary acquisition of Innovationbubble is further testament of the Group's ability to identify opportunities and act decisively."

 

 

CONTACT

 

THE MISSION GROUP PLC

James Clifton, Chief Executive

Peter Fitzwilliam, Chief Financial Officer

Tel: 020 7462 1415

SHORE CAPITAL (Nomad and Broker)

Mark Percy / James Thomas / Sarah Mather

 Tel: 020 7408 4090

 

HOUSTON (Financial PR and Investor Relations)

Kate Hoare / Laura Stewart

Tel: 0203 760 7668

NOTES TO EDITORS

About The MISSION Group PLC

MISSION is a collective of creative Agencies led by like-minded entrepreneurs with an independent spirit. Employing 1,150 people across 31 locations across Europe, Asia and the US, the Group successfully combines the expertise of integrated and specialist Agencies to bring about commercially effective solutions to business challenges for some of the world's biggest Clients. 

With an impressive track record of growth, MISSION has continued to acquire new Agencies with fantastic reputations, expanding its service capability even further.

The group also offers Fuse, a central innovation hub through which it has successfully trialled and developed a number of emerging technologies. Many of these have been grown into successful commercial products that bring value to the MISSION family of Agencies. 

 

www.themission.co.uk

 

ABOUT INNOVATIONBUBBLE

 

Innovationbubble is a specialist group of consumer, business, neuro and behavioural psychologists who, using their extensive commercial experience working with Clients, bring both understanding and interventions in terms of audience engagement.

 

Working across the globe, Innovationbubble has successfully supported businesses in finance, retail, FMCG, travel, technology and healthcare. Employing its unique psychological engines and techniques, Innovationbubble enables clients to work on reality rather than assumption, explaining what its data means from a behavioural point of view and revealing the hidden world of customer and employee decision making. It then works with Client teams to operationalise these scientific insights, utilising their existing understanding of consumers and employees, to make digital, sales and communication outputs more impactful.

 

Innovationbubble has won multiple awards, helping start-ups reach their next level of growth, established brands be leaders in their sector and those in a crowded market differentiate themselves successfully.

 

www.innovationbubble.eu

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAPPUCWMUPUGQC
Date   Source Headline
15th Jun 20261:00 pmRNSResult of AGM
15th Jun 20267:00 amRNSAGM Trading Update
4th Jun 20267:00 amRNSNotice of AGM and Posting of Annual Report
21st May 202611:46 amRNSDirector/PDMR Shareholding
1st May 20262:45 pmRNSHolding(s) in Company
28th Apr 202611:00 amRNSHolding(s) in Company
27th Mar 20264:50 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSFinal Results
20th Mar 202612:00 pmRNSNotice of Investor Presentation
18th Feb 20267:00 amRNSGrowth Share Scheme
13th Jan 20267:00 amRNSBoard Changes
13th Jan 20267:00 amRNSFull Year Trading Update
17th Oct 20257:00 amRNSDirectorate Change
10th Oct 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2025
12th Sep 20257:00 amRNSBOARD CHANGES
22nd Aug 20257:00 amRNSNOTICE OF RESULTS AND INVESTOR PRESENTATION
12th Aug 20254:22 pmRNSHolding(s) in Company
6th Aug 20256:24 pmRNSHolding(s) in Company
24th Jul 20257:00 amRNSTrading Update
1st Jul 20257:00 amRNSMISSION Group plc appoints John Carey as new CEO
16th Jun 20251:19 pmRNSResult of AGM
16th Jun 20257:00 amRNSAGM Trading Update
11th Jun 202511:44 amRNSNotice of AGM and Posting of Annual Report
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 202510:16 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
10th Mar 20257:00 amRNSInvestor Presentation
17th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20258:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNS2024 Full Year Trading Update
13th Jan 20259:30 amRNSHolding(s) in Company
10th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20253:47 pmRNSHolding(s) in Company
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSDirectorate Change
2nd Jan 20257:00 amRNSShare buyback programme
2nd Jan 20257:00 amRNSDisposal and Capital Allocation Update
21st Nov 20247:00 amRNSDirectorate Change
24th Sep 20247:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.